Skip to content
Clinical Trials – home

Find therapies in clinical trials near you – page 341

recruiting
3 967
countries
28
conditions
2 124

10 514 trials match your criteria

Invasive breast carcinoma+1

Not yet recruiting

Study on Time-Restricted Eating and Metformin for Patients with Invasive Breast Cancer or Ductal Carcinoma In Situ

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Metformin Hydrochloride

COVID-19

Not yet recruiting

Study on Immune Response in COVID-19 Recovered Patients Treated with Monoclonal Antibodies: Effects of Revaccination with Elasomeran, Tozinameran, and Cilgavimab

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Cilgavimab

Ischaemic stroke

Not yet recruiting

Study on Fibrinogen Replacement to Prevent Brain Bleeding in Stroke Patients After Thrombolysis

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Human Fibrinogen

Erectile dysfunction+1

Not yet recruiting

Study on Improving Sexual Function in Men and Women After Rectal Cancer Treatment Using Tadalafil

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Tadalafil

Urinary tract infection

Not yet recruiting

A study of fosfomycin trometamol treatment for male urinary tract infections in primary care settings

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Fosfomycin Trometamol

Transitional cell carcinoma

Not yet recruiting

Neoadjuvant Study of Avelumab with Gemcitabine and Cisplatin versus Chemotherapy Alone in Patients with High‑Grade Localized Upper Tract Urothelial Carcinoma

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Avelumab

Bacterial infection

Not yet recruiting

Subcutaneous Meropenem for Patients with Bacterial Infections: A Study of Cmax Differences on Day 5

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Meropenem

Immune response and safety of revaccination with respiratory syncytial virus glycoprotein F recombinant vaccine adjuvanted with AS01E in older adults

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:65+ years · Healthy volunteers
  • Substances:GSKVx000000017064

Malignant peritoneal neoplasm+2

Not yet recruiting

A Phase 3 Study of Raludotatug Deruxtecan With or Without Bevacizumab as Maintenance Therapy in Patients With Platinum‑Sensitive Recurrent Ovarian Cancer

Registered drugNo placebo
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab

Hypertension+1

Not yet recruiting

Assessing Baxdrostat to Identify Primary Aldosteronism in Adults Newly Diagnosed with Untreated Hypertension

InvestigationalNo placebo
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Baxdrostat

Ravulizumab versus plasma exchange for acute neuromyelitis optica attacks: a randomized trial in patients with first or relapsed episodes

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Ravulizumab

Efficacy and Safety of Sodium Valproate Added to Standard Therapy in Patients with Stable Pulmonary Arterial Hypertension – Phase 2b Randomized Study

Investigational
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Sodium Valproate
Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.